164 related articles for article (PubMed ID: 8556068)
1. Normal growth and pubertal development during bromocriptine therapy in two patients with prolactinoma.
Kamel N; Uysal AR; Cesur V; Erdoğan G; Başkal N
Endocr J; 1995 Aug; 42(4):581-6. PubMed ID: 8556068
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
Glaser B; Nesher Y; Barziliai S
J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and drug therapy of prolactinoma.
Ciccarelli E; Camanni F
Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
[TBL] [Abstract][Full Text] [Related]
4. Bromocriptine treatment of prolactinoma restores growth hormone secretion and causes catch-up growth in a prepubertal child.
Sakazume S; Obata K; Takahashi E; Yoshino A; Murakami N; Sakuta R; Murai T; Nagai T
Eur J Pediatr; 2004 Aug; 163(8):472-4. PubMed ID: 15160292
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment.
Zacharieva S; Stoeva I; Andreeva M; Kalinov K; Matrozov P; Andonova K
Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):593-7. PubMed ID: 9010834
[TBL] [Abstract][Full Text] [Related]
6. Potential for long-term remission of microprolactinoma after withdrawal of dopamine-agonist therapy.
Bronstein MD
Nat Clin Pract Endocrinol Metab; 2006 Mar; 2(3):130-1. PubMed ID: 16932269
[No Abstract] [Full Text] [Related]
7. High prolactin level.
Piketty ML; Nataf F; Dilouya A; Roux FX
J Neurosurg; 2000 Feb; 92(2):368-9. PubMed ID: 10659034
[No Abstract] [Full Text] [Related]
8. Normal growth and pubertal development during bromocriptine treatment for a prolactin-secreting pituitary macroadenoma.
Dalzell GW; Atkinson AB; Carson DJ; Sheridan B
Clin Endocrinol (Oxf); 1987 Feb; 26(2):169-72. PubMed ID: 3665115
[TBL] [Abstract][Full Text] [Related]
9. A case of large prolactinoma supposed to be cured by bromocriptine therapy.
Arita K; Uozumi T; Ohta M
Endocrinol Jpn; 1988 Jun; 35(3):503-9. PubMed ID: 3197661
[TBL] [Abstract][Full Text] [Related]
10. Late development of resistance to bromocriptine in a patient with macroprolactinoma.
Delgrange E; Crabbé J; Donckier J
Horm Res; 1998; 49(5):250-3. PubMed ID: 9568811
[TBL] [Abstract][Full Text] [Related]
11. Achievement of fertility in an infertile man with resistant macroprolactinoma using high-dose bromocriptine and a combination of human chorionic gonadotropin and an aromatase inhibitor.
Heidari Z; Hosseinpanah F; Shirazian N
Endocr Pract; 2010; 16(4):669-72. PubMed ID: 20439242
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of quinagolide in resistance to dopamine agonists: results of a multicenter study. Club de l'Hypophyse.
Rohmer V; Freneau E; Morange I; Simonetta C
Ann Endocrinol (Paris); 2000 Nov; 61(5):411-7. PubMed ID: 11084391
[TBL] [Abstract][Full Text] [Related]
13. Resolution of migraine following bromocriptine treatment of a prolactinoma (pituitary microadenoma).
Hartman N; Voron SC; Hershman JM
Headache; 1995; 35(7):430-1. PubMed ID: 7672963
[TBL] [Abstract][Full Text] [Related]
14. [Macroprolactinoma resistant to bromocriptine].
López-Espinosa E; Ayala AR; Grimaldo J; Kunhardt J; Villanueva C
Arch Invest Med (Mex); 1989; 20(1):1-8. PubMed ID: 2669670
[TBL] [Abstract][Full Text] [Related]
15. Macroprolactinomas as cause of delayed puberty. A report of two cases and effects of medical therapy.
Minniti G; Jaffrain-Rea ML; Ferretti E; Gulino A; Tamburrano G
Minerva Endocrinol; 1996 Jun; 21(2):67-71. PubMed ID: 8968149
[TBL] [Abstract][Full Text] [Related]
16. Prolactin-secreting macroadenomas in adolescents. Response to bromocriptine therapy.
Tyson D; Reggiardo D; Sklar C; David R
Am J Dis Child; 1993 Oct; 147(10):1057-61. PubMed ID: 8213676
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients.
Sabuncu T; Arikan E; Tasan E; Hatemi H
Intern Med; 2001 Sep; 40(9):857-61. PubMed ID: 11579944
[TBL] [Abstract][Full Text] [Related]
18. Combined cabergoline and recombinant human growth hormone treatment of an adolescent with a macroprolactinoma causing GH deficiency.
Cesario F; Borretta G; Meineri I; Muratori M; Pizzocaro A; Beck-Peccoz P
J Pediatr Endocrinol Metab; 1997; 10(2):231-6. PubMed ID: 9364359
[TBL] [Abstract][Full Text] [Related]
19. Sjögren's Syndrome Accompanied by Prolactinoma: a case report and literature review.
Oh YJ; Lee WS; Yoo WH; Hahm JR; Kim HO; Suh YS; Lee SI; Cheon YH
Int J Rheum Dis; 2017 Nov; 20(11):1823-1826. PubMed ID: 26355497
[No Abstract] [Full Text] [Related]
20. Large macroprolactinoma treated with bromocriptine alone.
Loh KC; Shlossberg AH
Ann Acad Med Singap; 1996 Nov; 25(6):886-9. PubMed ID: 9055023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
